Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB18 Vamorolone
D11000 Vamorolone (USAN/INN) <US>
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
D11000 Vamorolone
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D11000 Vamorolone
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11000 Vamorolone
DG02925 CYP3A5 substrate
D11000 Vamorolone
DG02924 UGT substrate
DG03184 UGT1A3 substrate
D11000 Vamorolone
DG03190 UGT2B7 substrate
D11000 Vamorolone
DG03181 UGT2B17 substrate
D11000 Vamorolone
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D11000 Vamorolone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D11000 Vamorolone (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11000
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11000
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11000
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11000